schizandrin has been researched along with Cardiovascular Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, C; Fan, XX; Kou, JP; Li, F; Yu, BY; Zhang, Y | 1 |
| Jiang, M; Kang, L; Li, Z; Liu, X; Wang, Y; Xu, L; Zhao, X | 1 |
2 other study(ies) available for schizandrin and Cardiovascular Stroke
| Article | Year |
|---|---|
A Strategy for Optimizing the Combination of Active Components Based on Chinese Medicinal Formula Sheng-Mai-San for Myocardial Ischemia.
Topics: Animals; Creatine Kinase, MB Form; Cyclooctanes; Disease Models, Animal; Drug Combinations; Drugs, Chinese Herbal; Ginsenosides; Heart; Isoproterenol; L-Lactate Dehydrogenase; Lignans; Medicine, Chinese Traditional; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Pituitary Hormones, Posterior; Polycyclic Compounds; Spirostans; Troponin I | 2018 |
A metabonomic study of cardioprotection of ginsenosides, schizandrin, and ophiopogonin D against acute myocardial infarction in rats.
Topics: Animals; Cyclooctanes; Drug Combinations; Drugs, Chinese Herbal; Ginsenosides; Lignans; Magnetic Resonance Spectroscopy; Male; Metabolome; Metabolomics; Myocardial Infarction; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Saponins; Spirostans | 2014 |